To date, more than 600 genes are known to cause tumors when their sequences are spoiled by a mutation. Yet there are other ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

New Jersey lawmakers are seeking to protect children from skin cancer risks by removing restrictions on sunscreen in schools, as the state is known for its sunny beaches and outdoor activities.

Experts believe they may have discovered an unlikely yet accessible treatment for the brain cancer glioblastoma - a ...

Common antidepressant ‘unexpectedly effective’ against aggressive brain tumours - The drug, named vortioxetine, costs around ...

Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer doctors can extend patients' life ...

Vortioxetine, an antidepressant, shows promise against glioblastoma in lab tests conducted by ETH Zurich, leading to forthcoming clinical trials. Glioblastoma is an incurable and fatal type of brain ...

Due to advances in prevention, early detection and treatment, the overall cancer death rate in the U.S. fell by 33% between ...

The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute to tumor cell growth, HER2. Despite this common trait, the development of ...

A nationwide clinical trial shows positive results for cancer patients with this common wasting syndrome. Researchers discovered a drug that safely and effectively helped cancer patients when they ...

On March 1, 2024, the U.S. FDA approved RYBREVANT in combination with chemotherapy (carboplatin-pemetrexed) for the first-line treatment of patients with locally advanced or metastatic NSCLC with EGFR ...

Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia (ku-KEK-see-uh), a common condition related to cancer that involves weight loss and ...